Discussion on Raw Material Methods and Specifications

  • Check with publisher
  • Published date: February 22, 2018
    • Fremont, California, United States

Overview:
Based on knowledge of the active and inactive ingredient's function and role in the finished dosage form, Compendia methods and specifications are clearly accepted by third parties and regulatory agencies.

Why should you Attend:
The FDA has Approved hundreds of inactive ingredients for thousands of products with various dosage forms (routes of administration). The quantities and quality of each inactive ingredient is critical to the function and design of the final product formulation.

Areas Covered in the Session:
Description of the API and excipient manufacturing process and facility
The supplier's commitment to conforming to appropriate excipient GMP requirements
Characterization of the composition of the excipient.
Acceptability of Standards from Alternative Compendia (BP/EP/JP)

Who Will Benefit:
Quality Assurance/Control
Product Development/Formulator/R&D Chemist
Analytical Chemist/QC Lab
Regulatory Affairs
Material Management

Speaker Profile:
Mr. Lamont Michael Fulton is President of Regulatory Direction LLc and has over Forty years of Pharmaceutical experience (26 in regulatory affairs CMC).He has had roles as both Manager and Director of Chemistry Manufacturing and Controls (CMC) Regulatory and labeling at both Branded (Merck, SmithKline, Wyeth) and Generic drugs firm (Mylan).

Event Fee: One Dial-in One Attendee Price: US$150.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com

Result 0 votes
Compliance4All
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Recent Updates of FDA 21 CFR 11 Add-On Inspections

    Recent Updates of FDA 21 CFR 11 Add-On Inspections

    Medical Sciences Fremont (California) January 24, 2018 Check with publisher

    Overview: This presentation will cover the scope, status and results of the surveillance inspections and what they may mean for the future of 21 CFR Part 11. This will enable you to determine whether your company is subject to the most common violati...

  • FDA regulations and the ICH GCP recommendations

    FDA regulations and the ICH GCP recommendations

    Medical Sciences Fremont (California) January 24, 2018 Check with publisher

    Overview: It will be important to see what the FDA regulations and the ICH GCP recommendations are in this regard. The key is that the PI and all clinical staff know and follow the research plan (Protocol) exactly as it is written. To do this is ethi...

  • 3rd International Conference & Exhibition on Tissue Preservation and Biobanking

    3rd International Conference & Exhibition on Tissue Preservation and Biobanking

    Medical Sciences San Francisco (California) November 28, 2016 Check with publisher

    Exploring Emerging Markets in Biobanking International Conference & Exhibition on Tissue Preservation and Biobanking Conference Series Conference Series has been instrumental in conducting international biobanking meetings for past two years, and...